MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis

Carcinogenesis

Volumn 33, Issue 11, 2012, Pages 2147-2154

  Wang, Kai ^a   Li, Juan ^a   Guo, Hong ^a   Xu, Xueqing ^a   Xiong, Gang ^a   Guan, Xingying ^a   Liu, Botao ^a   Li, Junxia ^a   Chen, Xuedan ^a   Yang, Kang ^a   Bai, Yun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; MICRORNA; RAP1 PROTEIN; RAP1A PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER PROGNOSIS; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; BINDING SITES; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; HUMANS; LUCIFERASES; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 2; MICRORNAS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RAP1 GTP-BINDING PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84868613310     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs259     Document Type: Article

References (42)

1. Jemal, A. et al. (2011) Global cancer statistics. CA. Cancer J. Clin., 61, 69-90.
2. Stahl, M. et al.; ESMO Guidelines Working Group. (2010) Esophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 21 Suppl 5, v46-v49.
3. Ye, Q. et al. (2011) MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13. Lab. Invest., 91, 778-787.
4. Esquela-Kerscher, A. et al. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
5. Berezikov, E. et al. (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell, 120, 21-24.
6. Pillai, R.S. (2005) MicroRNA function: multiple mechanisms for a tiny RNA? RNA, 11, 1753-1761.
7. Zamore, P.D. et al. (2005) Ribo-gnome: the big world of small RNAs. Science, 309, 1519-1524.
8. Carthew, R.W. (2006) Gene regulation by microRNAs. Curr. Opin. Genet. Dev., 16, 203-208.
9. Kong, K.L. et al. (2012) MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut, 61, 33-42.
10. Chen, Z.L. et al. (2011) microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem., 286, 10725-10734.
11. Ryan, B.M. et al. (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer, 10, 389-402.
12. Liu, Z. et al. (2011) A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Carcinogenesis, 32, 1668-1674.
13. Zhang, S. et al. (2012) REV3L 3'UTR 460 T>C polymorphism in micro-RNA target sites contributes to lung cancer susceptibility. Oncogene.
14. Sethupathy, P. et al. (2008) MicroRNA target site polymorphisms and human disease. Trends Genet., 24, 489-497.
15. Xiong, F. et al. (2011) Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer. Cancer Res., 71, 5175-5181.
16. Teo, M.T. et al. (2012) The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis, 33, 581-586.
17. Hattori, M. et al. (2003) Rap1 GTPase: functions, regulation, and malignancy. J. Biochem., 134, 479-484.
18. Kometani, K. et al. (2004) Rap1 and SPA-1 in hematologic malignancy. Trends Mol. Med., 10, 401-408.
19. Huang, M. et al. (2012) EGFR-dependent pancreatic carcinoma cell metastasis through Rap1 activation. Oncogene, 31, 2783-2793.
20. Bailey, C.L. et al. (2009) Activation of Rap1 promotes prostate cancer metastasis. Cancer Res., 69, 4962-4968.
21. Wang, L.D. et al. (2010) Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat. Genet., 42, 759-763.
22. Abnet, C.C. et al. (2010) A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat. Genet., 42, 764-767.
23. Altschuler, D.L. et al. (1998) Mitogenic and oncogenic properties of the small G protein Rap1b. Proc. Natl. Acad. Sci. U.S.A., 95, 7475-7479.
24. Gao, L. et al. (2006) Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res., 66, 7880-7888.
25. Singh, L. et al. (2003) The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins. J. Virol., 77, 1614-1620.
26. De Falco, V. et al. (2007) RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Res., 67, 381-390.
27. Zhang, Z. et al. (2006) Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am. J. Pathol., 168, 585-596.
28. Tsygankova, O.M. et al. (2007) Downregulation of Rap1GAP contributes to Ras transformation. Mol. Cell. Biol., 27, 6647-6658.
29. Tsygankova, O.M. et al. (2010) Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol. Cell. Biol., 30, 3262-3274.
30. Fralix, K.D. et al. (2003) Rap1 reverses transcriptional repression of TGFbeta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. J. Cell. Physiol., 194, 88-99.
31. Zuo, H. et al. (2010) Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors. Cancer Res., 70, 1389-1397.
32. Yajnik, V. et al. (2003) DOCK4, a GTPase activator, is disrupted during tumorigenesis. Cell, 112, 673-684.
33. Kataoka, M. et al. (1996) Matrix metalloproteinase 2 and 9 in esophageal cancer. Int. J. Oncol., 8, 773-779.
34. Mitra, R.S. et al. (2008) Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma. Cancer Res., 68, 3959-3969.
35. Yekta, S. et al. (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science, 304, 594-596.
36. Debernardi, S. et al. (2007) MicroRNA miR-181a correlates with morphological sub-class of acute myeloid leukaemia and the expression of its target genes in global genome-wide analysis. Leukemia, 21, 912-916.
37. Thorsteinsdottir, U. et al. (2002) Overexpression of the myeloid leukemiaassociated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood, 99, 121-129.
38. Hoffman, A.E. et al. (2009) microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res., 69, 5970-5977.
39. Luthra, R. et al. (2008) MicroRNA-196a targets annexin A1: a microRNAmediated mechanism of annexin A1 downregulation in cancers. Oncogene, 27, 6667-6678.
40. Bloomston, M. et al. (2007) MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA, 297, 1901-1908.
41. Maru, D.M. et al. (2009) MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am. J. Pathol., 174, 1940-1948.
42. Wang, K. et al. (2010) A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers, 15, 614-618.